Glycyrrhiza

About: Glycyrrhiza is a research topic. Over the lifetime, 1089 publications have been published within this topic receiving 19387 citations.

Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds

Abstract: The roots and rhizomes of licorice (Glycyrrhiza) species have long been used worldwide as a herbal medicine and natural sweetener. Licorice root is a traditional medicine used mainly for the treatment of peptic ulcer, hepatitis C, and pulmonary and skin diseases, although clinical and experimental studies suggest that it has several other useful pharmacological properties such as antiinflammatory, antiviral, antimicrobial, antioxidative, anticancer activities, immunomodulatory, hepatoprotective and cardioprotective effects. A large number of components have been isolated from licorice, including triterpene saponins, flavonoids, isoflavonoids and chalcones, with glycyrrhizic acid normally being considered to be the main biologically active component. This review summarizes the phytochemical, pharmacological and pharmacokinetics data, together with the clinical and adverse effects of licorice and its bioactive components.

A Drug over the Millennia : Pharmacognosy, Chemistry, and Pharmacology of Licorice

Abstract: Licorice, the root of Glycyrrhiza spp (Fabaceae), has been used since ancient Egyptian, Greek, and Roman times in the West and since the Former Han era (the 2nd-3rd century BC) in ancient China in the East In traditional Chinese medicine, licorice is one of the most frequently used drugs In Japan, the oldest specimen of licorice introduced from China in the middle of the 8th century still exists in Shosoin, the Imperial Storehouse, in Nara Extracts of licorice were recommended as a remedy for gastric ulcer by Revers of the Netherlands in 1946, which was soon withdrawn owing to its side effects Carbenoxolon sodium, glycyrrhetinic acid (GA) hemisuccinate Na, was prepared from licorice to treat peptic ulcer in the UK In Japan for the past 60 years, a glycyrrhizin (GL) preparation under the name of Stronger Neo-Minophagen C (SNMC) has been used clinically as an antiallergic and antihepatitis agent GL and GA sometimes induce edema, hypertension, and hypokalemia in patients treated with higher doses and long-term administration The mechanism of this side effect, pseudoaldosteronism, has been explained as due to the 11-hydroxy-steroid dehydrogenase inhibitory activity of GL and GA The excess of endogenous cortisol produced combines with the renal mineral corticoid receptor, which promotes an aldosterone-like action GL and GA reduce alanine transaminase (ALT) and aspartate transaminase (AST) values in the serum This hepatoprotective effect has recently been explained as the inhibitory effects of GL and GA on immune-mediated cytotoxicity against hepatocytes and on nuclear factor (NF)-kappa B, which activates genes encoding inflammatory cytokines in the liver To exclude the side effects and enhance the therapeutic activities, chemical modification of GL and GA has been performed Deoxoglycyrrhetol (DG), homo- and heteroannular diene homologs of dihemiphthalates, showed a remarkable improvement in antiinflammatory, antiallergic, and antiulcer activities in animal experiments Immunomodulating effects of GL, GA, and DG derivatives, which induce interferon-gamma and some other cytokines, have been demonstrated in relation with their antiviral activities Antiinflammatory, antitumorigenic, and antimalarial effects of licorice flavonoids have also been investigated